Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/acta.0.1290201
Acta Endocrinologica, Vol 129, Issue 3, 201-206
Copyright © 1993 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosén, T.
Right arrow Articles by Bengtsson, B.-A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosén, T.
Right arrow Articles by Bengtsson, B.-A.

RESEARCH-ARTICLE

Reduced bone mineral content in adult patients with growth hormone deficiency

Thord Rosén, Tommy Hansson, Hans Granhed, Janos Szucs and Bengt-Åke Bengtsson

Bone mineral content was measured in a follow-up study of adult patients with hypopituitarism and growth hormone deficiency. There were 95 patients (59 males, mean age 54.0 years, range 21–74 years; 36 females, mean age 53.5 years, range 31–73 years). Routine replacement therapy with cortisone acetate and L-thyroxine was given. All males that were gonadal deficient were on proper testosterone therapy, except in four patients who were treated separately. Bone mineral content (g/cm) was measured using dual-photon absorptiometry in the third lumbar vertebra. Bone mineral content in the patients was compared with a control population (N=413, 25–74 years of age). Bone mineral content was significantly lower in males (N= 55, p<0.05) compared with controls. In females, bone mineral content was significantly lower both among the subjects with untreated gonadal deficiency (p<0.001) and among those with treated gonadal deficiency and normal premenopausal gonadal function (p<0.005) compared with controls. To summarize, patients with hypopituitarism on routine replacement therapy but not growth hormone have a lower bone mineral content than the controls. The reduced bone mineral content might be a result of untreated growth hormone deficiency.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
J. Verhelst and R. Abs
Cardiovascular risk factors in hypopituitary GH-deficient adults
Eur. J. Endocrinol., November 1, 2009; 161(suppl_1): S41 - S49.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
A. Fernandez, M. Brada, L. Zabuliene, N. Karavitaki, and J. A H Wass
Radiation-induced hypopituitarism
Endocr. Relat. Cancer, September 1, 2009; 16(3): 733 - 772.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. E. Molitch, D. R. Clemmons, S. Malozowski, G. R. Merriam, S. M. Shalet, M. L. Vance, and for The Endocrine Society's Clinical Guidelines Su
Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1621 - 1634.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. D. White, A. M. Ahmad, B. H. Durham, S. Chandran, A. Patwala, W. D. Fraser, and J. P. Vora
Effect of Active Acromegaly and Its Treatment on Parathyroid Circadian Rhythmicity and Parathyroid Target-Organ Sensitivity
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 913 - 919.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. D. White, A. M. Ahmad, B. H. Durham, A. Patwala, P. Whittingham, W. D. Fraser, and J. P. Vora
Growth Hormone Replacement Is Important for the Restoration of Parathyroid Hormone Sensitivity and Improvement in Bone Metabolism in Older Adult Growth Hormone-Deficient Patients
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3371 - 3380.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. D. Murray, B. Columb, J. E. Adams, and S. M. Shalet
Low Bone Mass Is an Infrequent Feature of the Adult Growth Hormone Deficiency Syndrome in Middle-Age Adults and the Elderly
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1124 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Schweizer, D. D. Martin, C. P. Schwarze, G. Binder, A. Georgiadou, J. Ihle, and M. B. Ranke
Cortical Bone Density Is Normal in Prepubertal Children with Growth Hormone (GH) Deficiency, but Initially Decreases during GH Replacement due to Early Bone Remodeling
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5266 - 5272.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. A. Benbassat, V. Eshed, M. Kamjin, and Z. Laron
Are Adult Patients with Laron Syndrome Osteopenic? A Comparison between Dual-Energy X-Ray Absorptiometry and Volumetric Bone Densities
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4586 - 4589.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. G. Maheshwari, R. Bouillon, J. Nijs, V. S. Oganov, A. V. Bakulin, and G. Baumann
The Impact of Congenital, Severe, Untreated Growth Hormone (GH) Deficiency on Bone Size and Density in Young Adults: Insights from Genetic GH-Releasing Hormone Receptor Deficiency
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2614 - 2618.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 European Society of Endocrinology.